Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup

Joint Authors

Fernández, Maribel
Gómez-Ulla, Francisco
Charlón, Pablo
Gil, María

Source

Case Reports in Medicine

Issue

Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-10, 10 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2012-10-30

Country of Publication

Egypt

No. of Pages

10

Main Subjects

Medicine

Abstract EN

Purpose.

To show the long-term results of intravitreal ranibizumab combined with photodynamic therapy (PDT) for the treatment of polypoidal choroidal vasculopathy (PCV).

Methods.

We analyzed the progress of two patients for 36 and 58 months, respectively.

We only used PDT for the treatment in the area of the active PCV or “hot spot” evident on the indocyanine green angiography (ICGA).

The spot size was chosen so as to cover only the active neovascular lesion.

We combined intravitreal ranibizumab with PDT when PCV remained active without visible polyps in ICGA or without a response to PDT.

Conclusion.

Administration, as required, of verteporfin photodynamic therapy combined with intravitreal ranibizumab is an effective treatment for symptomatic polypoidal choroidal vasculopathy.

These data need to be confirmed in large, prospective, and controlled clinical trials which are randomized and carried out over a long period.

American Psychological Association (APA)

Fernández, Maribel& Gil, María& Gómez-Ulla, Francisco& Charlón, Pablo. 2012. Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup. Case Reports in Medicine،Vol. 2012, no. 2012, pp.1-10.
https://search.emarefa.net/detail/BIM-506347

Modern Language Association (MLA)

Fernández, Maribel…[et al.]. Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup. Case Reports in Medicine No. 2012 (2012), pp.1-10.
https://search.emarefa.net/detail/BIM-506347

American Medical Association (AMA)

Fernández, Maribel& Gil, María& Gómez-Ulla, Francisco& Charlón, Pablo. Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup. Case Reports in Medicine. 2012. Vol. 2012, no. 2012, pp.1-10.
https://search.emarefa.net/detail/BIM-506347

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-506347